Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Egenod

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2019
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessmentSami Antoun, Hugues Morel, Pierre-Jean Souquet, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2021
Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax RiskThomas Egenod, Jeremy Tricard, Romane Fumat, et al.
Respirology (Carlton, Vic.)|March 8, 2023
Impact of bronchoscopic lung volume reduction with endobronchial valves on dynamic hyperinflation: Results from the PIERCE studyRomane Fumat, Marion Dupuis, Siham Mallah, et al.
Respiratory Medicine and Research|January 11, 2023
Endobronchial valves: 1st Multicenter retrospective study on the 2-step approachThomas Egenod, Nicolas Guibert, Yoann Ammar, et al.
Archivos De Bronconeumologia|April 16, 2025
Role of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction Due to Small Cell Lung Cancer: Results From the EpiGETIF RegistryJulie Tronchetti, Pascalin Roy, Sophie Laroumagne, et al.
Journal for Immunotherapy of Cancer|October 21, 2022
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)Marie Wislez, Julien Mazieres, Armelle Lavole, et al.
ERJ Open Research|April 8, 2025
Prognostic factors after therapeutic bronchoscopy for tracheo- or broncho-oesophageal fistulas: results from the EpiGETIF registryJuliette Edme, Clément Fournier, Benoit Lepage, et al.
Frontiers in Oncology|March 16, 2023
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospitalSandra Pinet, Stéphanie Durand, Alexandre Perani, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2015
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world settingMarion Sassier, Audrey Emmanuelle Dugué, Bénédicte Clarisse, et al.
Annals of the American Thoracic Society|February 23, 2024
Outcomes of Therapeutic Bronchoscopy in Malignant Airway Obstruction Causing Acute Respiratory FailurePascalin Roy, Clément Fournier, Robby Barnestein, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2019
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessmentSami Antoun, Hugues Morel, Pierre-Jean Souquet, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2021
Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax RiskThomas Egenod, Jeremy Tricard, Romane Fumat, et al.
Respirology (Carlton, Vic.)|March 8, 2023
Impact of bronchoscopic lung volume reduction with endobronchial valves on dynamic hyperinflation: Results from the PIERCE studyRomane Fumat, Marion Dupuis, Siham Mallah, et al.
Respiratory Medicine and Research|January 11, 2023
Endobronchial valves: 1st Multicenter retrospective study on the 2-step approachThomas Egenod, Nicolas Guibert, Yoann Ammar, et al.
Archivos De Bronconeumologia|April 16, 2025
Role of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction Due to Small Cell Lung Cancer: Results From the EpiGETIF RegistryJulie Tronchetti, Pascalin Roy, Sophie Laroumagne, et al.
Journal for Immunotherapy of Cancer|October 21, 2022
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)Marie Wislez, Julien Mazieres, Armelle Lavole, et al.
ERJ Open Research|April 8, 2025
Prognostic factors after therapeutic bronchoscopy for tracheo- or broncho-oesophageal fistulas: results from the EpiGETIF registryJuliette Edme, Clément Fournier, Benoit Lepage, et al.
Frontiers in Oncology|March 16, 2023
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospitalSandra Pinet, Stéphanie Durand, Alexandre Perani, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2015
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world settingMarion Sassier, Audrey Emmanuelle Dugué, Bénédicte Clarisse, et al.
Annals of the American Thoracic Society|February 23, 2024
Outcomes of Therapeutic Bronchoscopy in Malignant Airway Obstruction Causing Acute Respiratory FailurePascalin Roy, Clément Fournier, Robby Barnestein, et al.
Pageof 3